Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of KIMIA BIOSCIENCES. For more details, see the KIMIA BIOSCIENCES quarterly results and KIMIA BIOSCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.5 |
No. of shares | m | 47.31 |
1 Week | % | -2.3 |
1 Month | % | -6.2 |
1 Year | % | 47.4 |
52 week H/L | Rs | 58.4/32.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
KIMIA BIOSCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 77 | 40 | 64 | 66 | 53 | |
Low | Rs | 30 | 19 | 20 | 35 | 30 | |
Sales per share (Unadj.) | Rs | 64.4 | 22.9 | 28.1 | 26.4 | 27.2 | |
Earnings per share (Unadj.) | Rs | 2.6 | 0.3 | 1.1 | -0.8 | -2.0 | |
Diluted earnings per share | Rs | 0.8 | 0.3 | 1.1 | -0.8 | -2.0 | |
Cash flow per share (Unadj.) | Rs | 3.4 | 0.7 | 1.5 | -0.2 | -1.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 2.8 | 2.9 | 3.9 | 3.1 | 1.2 | |
Adj. book value per share | Rs | 0.9 | 2.8 | 3.9 | 3.1 | 1.2 | |
Shares outstanding (eoy) | m | 14.59 | 46.35 | 47.31 | 47.31 | 47.31 | |
Price / Sales ratio | x | 0.8 | 1.3 | 1.5 | 1.9 | 1.5 | |
Avg P/E ratio | x | 20.2 | 99.1 | 38.9 | -64.5 | -21.0 | |
P/CF ratio (eoy) | x | 15.7 | 45.0 | 28.3 | -313.6 | -32.7 | |
Price / Book Value ratio | x | 18.8 | 10.2 | 10.8 | 16.0 | 36.0 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 777 | 1,369 | 1,986 | 2,389 | 1,968 | |
Total wages/salary | Rs m | 88 | 108 | 141 | 151 | 164 |
KIMIA BIOSCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 939 | 1,063 | 1,327 | 1,249 | 1,285 | |
Other income | Rs m | 13 | 10 | 25 | 9 | 13 | |
Total revenues | Rs m | 952 | 1,073 | 1,352 | 1,258 | 1,298 | |
Gross profit | Rs m | 56 | 45 | 84 | 6 | -61 | |
Depreciation | Rs m | 11 | 17 | 19 | 29 | 33 | |
Interest | Rs m | 20 | 25 | 34 | 36 | 42 | |
Profit before tax | Rs m | 38 | 12 | 55 | -50 | -124 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | -2 | 4 | -13 | -30 | |
Profit after tax | Rs m | 39 | 14 | 51 | -37 | -94 | |
Gross profit margin | % | 5.9 | 4.2 | 6.3 | 0.5 | -4.8 | |
Effective tax rate | % | -1.3 | -12.6 | 7.8 | 26.2 | 24.5 | |
Net profit margin | % | 4.1 | 1.3 | 3.8 | -3.0 | -7.3 |
KIMIA BIOSCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 475 | 609 | 701 | 731 | 827 | |
Current liabilities | Rs m | 304 | 386 | 509 | 618 | 764 | |
Net working cap to sales | % | 18.2 | 21.0 | 14.5 | 9.0 | 4.9 | |
Current ratio | x | 1.6 | 1.6 | 1.4 | 1.2 | 1.1 | |
Inventory Days | Days | 1 | 5 | 2 | 1 | 1 | |
Debtors Days | Days | 1,132 | 1,282 | 1,149 | 883 | 869 | |
Net fixed assets | Rs m | 178 | 247 | 348 | 355 | 346 | |
Share capital | Rs m | 21 | 47 | 47 | 47 | 47 | |
"Free" reserves | Rs m | 20 | 86 | 137 | 102 | 7 | |
Net worth | Rs m | 41 | 134 | 184 | 149 | 55 | |
Long term debt | Rs m | 241 | 243 | 283 | 244 | 308 | |
Total assets | Rs m | 654 | 857 | 1,067 | 1,086 | 1,173 | |
Interest coverage | x | 2.9 | 1.5 | 2.6 | -0.4 | -1.9 | |
Debt to equity ratio | x | 5.8 | 1.8 | 1.5 | 1.6 | 5.6 | |
Sales to assets ratio | x | 1.4 | 1.2 | 1.2 | 1.2 | 1.1 | |
Return on assets | % | 8.9 | 4.6 | 8.0 | -0.1 | -4.4 | |
Return on equity | % | 93.1 | 10.3 | 27.7 | -24.9 | -171.2 | |
Return on capital | % | 20.5 | 10.0 | 19.1 | -3.5 | -22.4 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 2 | 45 | 0 | 0 | 0 | |
Fx outflow | Rs m | 594 | 610 | 0 | 0 | 0 | |
Net fx | Rs m | -592 | -565 | 0 | 0 | 0 |
KIMIA BIOSCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -27 | 3 | 60 | 80 | -68 | |
From Investments | Rs m | -22 | -86 | -136 | -7 | -28 | |
From Financial Activity | Rs m | 44 | 85 | 80 | -77 | 95 | |
Net Cashflow | Rs m | -5 | 1 | 4 | -4 | -0 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sameer Goel | COMP SEC: Abhishek Kumar Pandey | YEAR OF INC: 1993 | BSE CODE: 530313 | FV (Rs): 1 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare KIMIA BIOSCIENCES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.